Open AccessPD59-02 IMPACT OF 5?-REDUCTASE INHIBITORS AND ?-BLOCKERS FOR BENIGN PROSTATIC HYPERPLASIA ON PROSTATE CANCER INCIDENCE AND MORTALITY
Author(s) -
Maria Van Rompay,
Gayatri Ranganathan,
Philip W. Kantoff,
Keith R. Solomon,
Jennifer L. Lund,
John B. McKinlay,
J. Curtis Nickel
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.2802
Subject(s) - medicine , incidence (geometry) , prostate cancer , hyperplasia , cancer , prostate , dutasteride , gynecology , retrospective cohort study , cohort , proportional hazards model , 5 alpha reductase inhibitor , oncology , urology , finasteride , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom